Antipsychotics Flashcards

1
Q

Striatal interneuron

A

Ach Containing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nigrostraital

A

A9 Dopamine neuron Substantia nagra pars compacta- Corpus striatum
DA release in straitum is essental for normal extrapyramidal motor function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Striatonigral

A

GABAnergic Neuron VTA-Corpus Striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mesolimbic

A

A10 DA neuron VTA- Nucleus accumbens

DA release is important for normal affect, orderly thinking, drive states, pleasure/reward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DA receptor subtypes

A

D1 (D1,D5)

D2 (D2,D3,D4) Exist in 2 isoforms D2 long, D2 short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

D1 receptors

A

Stimulate adenylate cyclase and increase cAMP
Affinity for phenothiazines > butyrophenones
small intracellular loop, large carboxy tail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

D2 receptors

A

Not associated w/stimulation of Adenyate cyclase and may inhibit it
Affinity for butyrophenones > phenothiazines
Large intracellular loop, small carboxy tail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DA receptors are…

A

GPCRs

7 transmembrane spanning receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

D1 couple

A

Gs, Golf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

D2 couple

A

Gi/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms and diagnosis of psychosis

A

Charecterized by impared behavior. Inability to think coherrently and comprehend reality.
+ve symptoms- “added” hallucinations, delusions, paranoia etc.
-ve symptoms- withdrawl, depersonalization
cognative- impared attention, deficits in learning and memory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Organic Psychosis

A

Known cause. Can be due to:

Impared cerebral tissue function, intellecutual decline, drug abuse, tramua etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Idiopathic psychosis

A

Cause is not known. May have a genetic component (twin studies)
Schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dopamine theory

A

Upregulation of dopamine, excessive DA transmission- in limbric striatum and cortical areas innervted by A10 causes Schizophrenia.
* Terminal regions of A10 Dopamine pathways- Limbic cortex, and nucleus accumbens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Evidence for DA theory

A

Drugs blocking D2 like receptors reduce psychotic symptoms (+ve)
Drugs increasing synaptic DA cause psychosis (amphetamines, LDOPA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Problems with DA theory

A

Other transmitter systems (seratonin, glutamate) and brain areas (Cortex, thalamus) are also likely involved
This theory alone is not enough to explain schitzophrenia. Multiple genes/systems are likely involved
Upregulation of dopa- negative symptoms??!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pharmacological basis of therapuetics in Schizophrenia

A

Reduce DA transmission in terminal regions (A10 mesolimbic)
D2 blockers
Therapeutic problems arise as its difficult to block DA receptors only in limbic terminal areas (leading to SAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Classes of Antipyschotics

A

Typical- older generation- blockade D2 w/greater affinity than 5-HT2A
Atypical- newer generation- blockade 5-HT2A> D2 receptors. 2nd & 3rd Generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Typical antipsychotic classes

A

Phenothiazine
Thioxanthene
Butyrophenone

Miscellaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Chlorpromazine

A

Phenothiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thioridazine

A

Phenothiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Trifluoperazine

A

Phenothiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Perphenazine

A

Phenothiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Fluphenazine

A

Phenothiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Haloperidol

A

Butyrophenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Pimozide

A

Misc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Loxapine

A

A-typical

dibenzoxazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Clozapine

A
dibenzodiazepine
A-typical
No extrapyramidal SAs
May suppress tardive dyskinesia
Effective in drug resistant cases- reduces +/- symptoms
Blocks many receptors besides DA- muscarinic, 5-HT2A, a1, h1. 
D4 blockade as well
D4=a1>5HT2A>D2=D1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Risperidone

A

A-typical

Low incidence of extrapyramidal and tardive dyskinesia. D2 5HT receptor blocking

30
Q

Quetiapine

A

A-typical
H1>a1>D2>5HT2A
low incidence of extrapyramidals
+/- symptoms

31
Q

Olanzapine

A
A-typical
5HT2A>H1>D4>D2
\+/- Symptoms
Low incidence of extrapyramidal
Weight gains!
32
Q

Ziprasidone

A

A-typical
Acute treatment for agitated or violent encounters
Serious cardiac arrhythmias

33
Q

Aripiprazole

A

A-typical- 3rd generation
Partial agonist D2=5HT2A>D4>A1=H1»D1
DA stabilizer since its a partial.
No extrapyrmaidals

34
Q

Receptors

A

All have similar binding pockets, all ligands are monoamine NTs

35
Q

CNS SA’s

A

Sedation- tolerance
Antianxiety- +ve!
Suppression of spontaneous movement, lack of initative, disinerest, lack of pleasure

36
Q

Endocrine SA’s

A

Increased Prolactin- causing breast enlargement in males. Increased female and decreased male libido. Inc appetite, weight gain.

More prominent in typical antipsychotics and risperidone

37
Q

Autonomic SA’s

A
Anticholinergic- muscarinic blockade (ACh) blurred vision, dry mouth
Antiadrenergic effects (GPCR)- orthostatic hypotention and reflex tachycardia
38
Q

Cardio SA’s

A

Hypotention

39
Q

Blood Disorders

A

Decrease WBC- leukopenia
Increase certain elements (eosinophilia)
Clozapine- can cause bone marrow suspension and frank agranulocytosis

40
Q

EPS SA’s

A

More common w/typical.

41
Q

Parkinsonian

A

EPS

5-30 day onset.
Treatment w/anticholinergic drugs

42
Q

Acute Dystonic Rxn

A

1-5 day onset- spasms of muscles in face, back, mimic seizures
Treatable w/anticholinergics

43
Q

Akathisia

A

5-6 day onset; restlessness

Reduce dose of antipsych to treat

44
Q

Neuroleptic Malignant Syndrome

A

Onset is weeks.
Can persist for days after stopping a neuroleptic.
Fever, unstable BP, can be fatal
STOP antipsychotic, dantrolene or bromocriptine may help.

45
Q

Tardive dyskinesia

A

Months to years
Irreversible orofacial dyskinesias
No effective treatment
Prevention- use lowest effective dose of antipyscs.

46
Q

Skin Reactions

A

Phenothiazines

47
Q

Lowering of seizure threshold

A

Contraindicated during alc withdrawl or CNS depression

48
Q

Interactions

A

Potentiates effects of CNS Depressents, sedative/hypnotics, alcs, antihistamines, opiates.

49
Q

Asenapine

A

Atypical
Schizophrenia and acute manic episodes BPD
Reduced extrapyramidal symptoms, no changes in prolactin

50
Q

Lurasidone

A

Atypical
MDD BPD
Blocks 5HT2A, D2, AND 5HT7 w/high affinity
Extrapyramidal- akathisia (restlessness)

51
Q

Other uses

A

Huntingtons

Tourettes

52
Q

1st Generation Antipsyhcs

A

Typical, block +ve symptoms.

Little to no discrimination between D2-D1

53
Q

2nd Generation Antipsychs

A

Selective for D2, HT2A

+’ve symptoms, -ve symptoms

54
Q

3rd Generation Antipsychs

A

Partial agonists.

No metabolate syndrome

55
Q

Phenothiazine Derivatives

A

Phenol, Sulfer, Nitrogen.
Non-selective DA antagonist.
Lipophobic- good to pass BBB
some Hydrophillic properties- needed to dissolve and absorb in GI

56
Q

Long Acting Neuroleptics

A

Increase patient compliance. More lipophillic in nature, injected IM.
Prodrug design- not active. Bioactivation occurs via esterases in blood stream.

57
Q

Alkyl chain size for optimal antipsychotic activity

A
  1. 2c- antihystamines
    1c, 4c+ do not work
58
Q

Antipsychotic potency trend

A

Piperazine>piperidine>aliphatics

59
Q

EPS frequency trend

A

Piperazine>piperidine>aliphatics

60
Q

Sedation trend

A

Aliphatics~piperidines>piperazines

61
Q

Hypotensive effects

A

Aliphatics>piperidines>piperazines

62
Q

Metabolism of Phenothiazines and Thioxanthenes

A

Oxidase Demethylate, -OH addition, sulfoxides, sulfones

63
Q

Butyropheones SAR

A

3’ Amino group is essential for neuroleptic activity
Variations on 3’ amino group, ie rings retain activity
Lengthening alkyl chain- reduces activity (dont want >3carbons)

64
Q

-OH/COOH on a butyrophenone

A

Conversion top a LA Neuroleptic. Esterify it.

65
Q

Metabolism of Haloperidol

A

Extensively metabolized in the body. See pic

Potentt neuroleptic- associated with high incidence of TD.

66
Q

Dibenzazepines

A

Neuroleptics that utilize Tricyclic dibenzazepine heterocyte.
Lipophillic, weakly basic.

67
Q

Dibenzodiazepine

A

X substituted for: NH

ex. Clozapine, Olanzapien

68
Q

Dibenzoxazepine

A

X substituted for: O

ex. Loxapine, Amoxapine

69
Q

Dibenzothiazepine

A

X substituted for: S

ex. Quetiapine

70
Q

Benzisoxazoles

A

Risperidone
balanced DA/5HT2A antagonism
Reduced EPS, +/- effects

71
Q

Risperidone Metabolism

A

Alicyclic hydroxylation, Oxidative N-dealkylation, Benzisooxazole Ring clevage